UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Rapidly involuting congenital hemangioma (RICH) and noninvoluting congenital hemangioma (NICH)

Authors
Ilona J Frieden, MD
Denise Adams, MD
Section Editor
Moise L Levy, MD
Deputy Editor
Rosamaria Corona, MD, DSc

INTRODUCTION

Congenital hemangiomas (CH) are rare, benign vascular tumors that, unlike infantile hemangiomas (IH), are present and fully grown at birth. They present as bossed plaques or exophytic masses located on the head, neck, or limbs (picture 1A-B). Based upon their natural history, two major subtypes of CH have been recognized: rapidly involuting congenital hemangiomas (RICH) and noninvoluting congenital hemangiomas (NICH) [1,2]. In most cases, RICH involute completely by the age of 14 months, whereas NICH never regress but grow in proportion with the child and may require eventual excision. A third intermediate subtype, the so-called partially involuting congenital hemangioma (PICH), shows overlapping features of RICH and NICH [3].

CH will be discussed in this topic. IH and other vascular tumors of childhood and capillary malformations are discussed separately.

(See "Infantile hemangiomas: Epidemiology, pathogenesis, clinical features, and complications".)

(See "Evaluation and diagnosis of infantile hemangiomas" and "Management of infantile hemangiomas".)

(See "Management of infantile hemangiomas".)

                        

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Wed Apr 06 00:00:00 GMT+00:00 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Boon LM, Enjolras O, Mulliken JB. Congenital hemangioma: evidence of accelerated involution. J Pediatr 1996; 128:329.
  2. Enjolras O, Mulliken JB, Boon LM, et al. Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly. Plast Reconstr Surg 2001; 107:1647.
  3. Nasseri E, Piram M, McCuaig CC, et al. Partially involuting congenital hemangiomas: a report of 8 cases and review of the literature. J Am Acad Dermatol 2014; 70:75.
  4. Kanada KN, Merin MR, Munden A, Friedlander SF. A prospective study of cutaneous findings in newborns in the United States: correlation with race, ethnicity, and gestational status using updated classification and nomenclature. J Pediatr 2012; 161:240.
  5. Yang B, Li L, Zhang LX, et al. Clinical Characteristics and Treatment Options of Infantile Vascular Anomalies. Medicine (Baltimore) 2015; 94:e1717.
  6. Krol A, MacArthur CJ. Congenital hemangiomas: rapidly involuting and noninvoluting congenital hemangiomas. Arch Facial Plast Surg 2005; 7:307.
  7. North PE, Waner M, James CA, et al. Congenital nonprogressive hemangioma: a distinct clinicopathologic entity unlike infantile hemangioma. Arch Dermatol 2001; 137:1607.
  8. North PE, Waner M, Mizeracki A, Mihm MC Jr. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000; 31:11.
  9. Mulliken JB, Enjolras O. Congenital hemangiomas and infantile hemangioma: missing links. J Am Acad Dermatol 2004; 50:875.
  10. Picard A, Boscolo E, Khan ZA, et al. IGF-2 and FLT-1/VEGF-R1 mRNA levels reveal distinctions and similarities between congenital and common infantile hemangioma. Pediatr Res 2008; 63:263.
  11. Ritter MR, Dorrell MI, Edmonds J, et al. Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis. Proc Natl Acad Sci U S A 2002; 99:7455.
  12. Lee PW, Frieden IJ, Streicher JL, et al. Characteristics of noninvoluting congenital hemangioma: a retrospective review. J Am Acad Dermatol 2014; 70:899.
  13. Berenguer B, Mulliken JB, Enjolras O, et al. Rapidly involuting congenital hemangioma: clinical and histopathologic features. Pediatr Dev Pathol 2003; 6:495.
  14. Trindade F, Tellechea O, Torrelo A, et al. Wilms tumor 1 expression in vascular neoplasms and vascular malformations. Am J Dermatopathol 2011; 33:569.
  15. Al Dhaybi R, Powell J, McCuaig C, Kokta V. Differentiation of vascular tumors from vascular malformations by expression of Wilms tumor 1 gene: evaluation of 126 cases. J Am Acad Dermatol 2010; 63:1052.
  16. Browning JC, Metry DW. Rapidly involuting congenital hemangioma: case report and review of the literature. Dermatol Online J 2008; 14:11.
  17. Roncero M, Martinez de Salinas A, Izquierdo N, Unamuno P. Rapidly involuting congenital haemangioma. Clin Exp Dermatol 2009; 34:937.
  18. Mulliken JB, Bischoff J, Kozakewich HP. Multifocal rapidly involuting congenital hemangioma: a link to chorangioma. Am J Med Genet A 2007; 143A:3038.
  19. Vildy S, Macher J, Abasq-Thomas C, et al. Life-threatening hemorrhaging in neonatal ulcerated congenital hemangioma: two case reports. JAMA Dermatol 2015; 151:422.
  20. Hughes R, McAleer M, Watson R, et al. Rapidly involuting congenital hemangioma with pustules: two cases. Pediatr Dermatol 2014; 31:398.
  21. Ozcan UA. Rapidly involuting congenital hemangioma: a case of complete prenatal involution. J Clin Ultrasound 2010; 38:85.
  22. Lopez-Gutierrez JC, Diaz M, Ros Z. Giant rapidly involuting congenital hemangioma of the face: 15-year follow-up. Arch Facial Plast Surg 2005; 7:316.
  23. Kulungowski AM, Alomari AI, Chawla A, et al. Lessons from a liver hemangioma registry: subtype classification. J Pediatr Surg 2012; 47:165.
  24. Roebuck D, Sebire N, Lehmann E, Barnacle A. Rapidly involuting congenital haemangioma (RICH) of the liver. Pediatr Radiol 2012; 42:308.
  25. Zenzen W, Perez-Atayde AR, Elisofon SA, et al. Hepatic failure in a rapidly involuting congenital hemangioma of the liver: failure of embolotherapy. Pediatr Radiol 2009; 39:1118.
  26. Powell J, Blouin MM, David M, Dubois J. Bleeding in congenital hemangiomas: crusting as a clinical predictive sign and usefulness of tranexamic acid. Pediatr Dermatol 2012; 29:182.
  27. Agesta N, Boralevi F, Sarlangue J, et al. Life-threatening haemorrhage as a complication of a congenital haemangioma. Acta Paediatr 2003; 92:1216.
  28. Nolan M, Hartin CW Jr, Pierre J, Ozgediz DE. Life-threatening hemorrhage from a congenital hemangioma caused by birth trauma. J Pediatr Surg 2012; 47:1016.
  29. Baselga E, Cordisco MR, Garzon M, et al. Rapidly involuting congenital haemangioma associated with transient thrombocytopenia and coagulopathy: a case series. Br J Dermatol 2008; 158:1363.
  30. Weitz NA, Lauren CT, Starc TJ, et al. Congenital cutaneous hemangioma causing cardiac failure: a case report and review of the literature. Pediatr Dermatol 2013; 30:e180.
  31. Andreu-Barasoain M, Naz E, Díaz M, López-Estebaranz JL. Rapidly involuting congenital hemangioma associated with transient anemia and thrombocytopenia. Int J Dermatol 2013; 52:1025.
  32. Rangwala S, Wysong A, Tollefson MM, et al. Rapidly involuting congenital hemangioma associated with profound, transient thrombocytopenia. Pediatr Dermatol 2014; 31:402.
  33. Hsiao CH, Tsao PN, Hsieh WS, Chou HC. Huge, alarming congenital hemangioma of the scalp presenting as heart failure and Kasabach-Merritt syndrome: a case report. Eur J Pediatr 2007; 166:619.
  34. Frieden IJ, Rogers M, Garzon MC. Conditions masquerading as infantile haemangioma: Part 1. Australas J Dermatol 2009; 50:77.
  35. Gorincour G, Kokta V, Rypens F, et al. Imaging characteristics of two subtypes of congenital hemangiomas: rapidly involuting congenital hemangiomas and non-involuting congenital hemangiomas. Pediatr Radiol 2005; 35:1178.
  36. Rogers M, Lam A, Fischer G. Sonographic findings in a series of rapidly involuting congenital hemangiomas (RICH). Pediatr Dermatol 2002; 19:5.
  37. Konez O, Burrows PE, Mulliken JB, et al. Angiographic features of rapidly involuting congenital hemangioma (RICH). Pediatr Radiol 2003; 33:15.
  38. Elia D, Garel C, Enjolras O, et al. Prenatal imaging findings in rapidly involuting congenital hemangioma of the skull. Ultrasound Obstet Gynecol 2008; 31:572.
  39. Frieden IJ, Rogers M, Garzon MC. Conditions masquerading as infantile haemangioma: Part 2. Australas J Dermatol 2009; 50:153.
  40. Gengler C, Guillou L. Solitary fibrous tumour and haemangiopericytoma: evolution of a concept. Histopathology 2006; 48:63.
  41. Variend S, Bax NM, van Gorp J. Are infantile myofibromatosis, congenital fibrosarcoma and congenital haemangiopericytoma histogenetically related? Histopathology 1995; 26:57.
  42. Mentzel T, Calonje E, Nascimento AG, Fletcher CD. Infantile hemangiopericytoma versus infantile myofibromatosis. Study of a series suggesting a continuous spectrum of infantile myofibroblastic lesions. Am J Surg Pathol 1994; 18:922.
  43. Pham NS, Poirier B, Fuller SC, et al. Pediatric lipoblastoma in the head and neck: a systematic review of 48 reported cases. Int J Pediatr Otorhinolaryngol 2010; 74:723.
  44. Astner S, Anderson RR. Treating vascular lesions. Dermatol Ther 2005; 18:267.
  45. Maguiness SM, Frieden IJ. Management of difficult infantile haemangiomas. Arch Dis Child 2012; 97:266.